Nerve Growth Factor Eye Drops Show Four-Year Safety in Children With Optic Pathway Gliomas
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A four-year observational follow-up of children treated with nerve growth factor eye drops in a randomized phase II trial shows ...
A phase II trial found that adjuvant sintilimab monotherapy after surgery met its primary efficacy endpoint with 87.5 percent one-year ...
A phase II trial of radiotherapy followed by atezolizumab in relapsed small cell lung cancer found that radiation-induced changes in ...
A phase II trial found that neoadjuvant camrelizumab plus apatinib, a chemotherapy-free combination of immunotherapy and anti-angiogenic therapy, produced manageable ...
A phase II trial found that nanoparticle polymeric micellar paclitaxel combined with carboplatin and sintilimab produced an objective response rate ...
The first randomised trial comparing microwave ablation with stereotactic body radiotherapy for oligometastatic colorectal liver metastases found similar local control ...
A prospective Phase II trial in Japan found that biweekly gemcitabine plus nab-paclitaxel produced a 47.1 percent response rate and ...
The phase II DETECT IVb trial confirms eribulin's efficacy and safety in HER2-negative metastatic breast cancer and shows that early ...
An Ethiopian randomized trial found that a single session of thermotherapy achieved cure rates comparable to weekly intralesional sodium stibogluconate ...
A multicentre Phase II trial found that neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil before transoral surgery allowed 91 percent ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine